Why there should be road-mapping for implementation of Mosquirix(anti malaria) vaccine...
Last Wednesday was a historical moment when WHO approves RTS,(s) vaccine namely -Mosquirix as Anti Malaria Vaccine to administer against the deadliest malaria pathogen. The study had been conducted over 5 years(2009---2014) in sub-Saharan Africa & in other regions. among the children (5 to 17)months & after 4 doses it was found that vaccine(RTS,S) could prevent 39%cases of malaria & 29% in case of severe malaria. Pilot phases had been initiated in Ghana, Kenia & Malawi where such activities were conducted among more than 800,000 nos of children & % of protection had been jumped to 90% . From its result, WHO had taken the decision for its approval. This vaccine which is the successful impact of the last 30 years of research had been manufactured with the British official partner-GlaxoSmithKline & indeed is the first vaccine for any parasitic disease. In India, there is a total of 2% of total morbidity due